The San Antonio Report’s 2021 Medical Forum series concluded Thursday with a discussion about how the coronavirus pandemic has underscored the potential for the San Antonio Partnership for Precision Therapeutics.

The leaders from the four institutions involved in the partnership participated in an online panel discussion moderated by San Antonio Report Editor Robert Rivard, including Dr. William Henrich, president of UT Health San Antonio; Dr. Larry Schlesinger, president and CEO of Texas Biomedical Research Institute; Adam Hamilton, president and CEO of the Southwest Research Institute, and Taylor Eighmy, president of the University of Texas at San Antonio. Jenna Saucedo-Herrera, president and CEO of Greater: SATX also participated.

The partnership aims to harness the science of precision medicine and its potential to impact medical diagnosis and treatment, as well as raise San Antonio’s profile as a key hub for biomedical research.

The collaborative nature of scientific research has been on full display during the pandemic, said Schlesinger.

“We’re in our labs doing research, but the scientists talk almost daily by Zoom or some other platform because we have to share the information,” he said. “If you don’t share the information, the science isn’t going to go anywhere.

“Science is a collaborative effort by definition. The reason we got to a vaccine in 11 months is that virtual platforms enabled the global community to talk to each other on a daily basis. … That really is team science.”

San Antonio Report Staff

This article was assembled by various members of the San Antonio Report staff.